• About us
• Contact

Advertisement

Organisation › Details

Nasdaq OMX (Group)

	Start	1971-01-01 established pred
	Industry	finance
	City	n. a.
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		Record changed: 2018-10-31

Advertisement

More documents for Nasdaq OMX (Group)

• [1] Anbio Biotechnology. (2/20/25). "Press Release: Anbio Biotechnology Announces Closing of Initial Public Offering". Frankfurt a. M.....
• [2] Anbio Biotechnology. (2/18/25). "Press Release: Anbio Biotechnology Announces Pricing of Initial Public Offering". Frankfurt a. M.....
• [3] Evaxion Biotech A/S. (1/28/25). "Press Release: Evaxion Granted 180-day Compliance Extension by Nasdaq as It Restores Equity above Minimum Requirement". Copenhagen....
• [4] Camp4 Therapeutics Corporation. (10/10/24). "Press Release: Camp4 Announces Pricing of Initial Public Offering". Cambridge, MA....
• [5] Centogene N.V.. (8/7/24). "Press Release: Centogene Receives Delisting Notice From Nasdaq". Cambridge, MA, Rostock & Berlin....
• [6] Affimed N.V.. (3/6/24). "Press Release: Affimed Announces 1-for-10 Reverse Stock Split". Mannheim....
• [7] Centogene N.V.. (2/28/24). "Press Release: Centogene Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing". Cambridge, MA, Rostock & Berlin....
• [8] Abivax S.A.. (10/24/23). "Press Release: Abivax Announces Closing of its Initial Public Offering on the Nasdaq Global Market". Paris....
• [9] Abivax S.A.. (10/20/23). "Press Release: Abivax Announces the Pricing of Its Initial Public Offering on the Nasdaq Global Market". Paris....
• [10] Abivax S.A.. (9/29/23). "Press Release: Abivax Files Registration Statement for Proposed Initial Public Offering in the United States". Paris....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.